<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/250365-2-3-dihydro-6-nitroimidazo-2-1-b-oxazole-compound by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 14:28:43 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 250365:2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUND</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUND</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The present invention provides a 2,3-dihydro- 6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R2 represents a group -OR3 or the like, and R3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R1 and -(CH2)nR2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug- resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>DESCRIPTION<br>
2,3-DIHYDRO-6-NITROIMIDAZO[2,l-b]OXAZOLE COMPOUND<br>
TECHNICAL FIELD<br>
The present invention relates to a 2,3-<br>
dihydroimidazo[2,1-b]oxazole compound.<br>
BACKGROUND ART<br>
From among acid-fast bacteria, human<br>
Mycobacterium tuberculosis has been widely known. It<br>
is said that the one-third of the human population is<br>
infected with this bacterium. In addition to the human<br>
Mycobacterium tuberculosis , Mycobacterium africanum and<br>
Mycobacterium bovis have also been known to belong to<br>
the Mycobacterium tuberoculosis group. These bacteria<br>
are known as Mycobacteria having a strong pathogenicity<br>
to humans.<br>
Against these tuberculoses, treatment is<br>
carried out using three agents, rifampicin, isoniazid,<br>
and ethambutol (or streptomycin) that are regarded as<br>
first-line agents, or using four agents such as the<br>
above three agents and pyrazinamide.<br>
However, since the treatment of tuberculosis<br>
requires extremely long-term administration of agents,<br>
it might result in poor compliance, and the treatment<br>
often ends in failure.<br>
Moreover, in respect of the above agents, it<br>
has been reported that: rifampicin causes hepatopathy,<br>
flu syndrome, drug allergy, and its concomitant<br>
administration with other drugs is contraindicated due<br>
to P450-associated enzyme induction; that isoniazid<br>
causes peripheral nervous system disorder and induces<br>
serious hepatopathy when used in combination with<br>
rifampicin; that ethambutol brings on failure of<br>
eyesight due to optic nerve disorder; that streptomycin<br>
brings on diminution of the hearing faculty due to the<br>
8th cranial nerve disorder; and that pyrazinamide<br>
causes adverse reactions such a hepatopathy, gouty<br>
attack associated with increase of uric acid level,<br>
vomiting (A Clinician's Guide To Tuberculosis, Michael<br>
D. Iseman 2000 by Lippincott Williams &amp; Wilkins,<br>
printed in the USA, ISBN 0-7817-1749-3, Tuberculosis,<br>
2nd edition, Fumiyuki Kuze and Takahide Izumi, Igaku-<br>
Shoin Ltd., 1992).<br>
Actually, it has been reported that cases<br>
where the standard chemotherapy could not be carried<br>
out due to the adverse reactions to these agents made<br>
up 70% (approximately 23%, 52 cases) of the total cases<br>
where administration of the agents was discontinued<br>
(the total 228 hospitalized patients who were subject<br>
to the research) (Kekkaku, Vol. 74, 77-82, 1999).<br>
In particular, hepatotoxicity, which is<br>
induced by rifampicin, isoniazid, and ethambutol out of<br>
the 5 agents used in combination for the aforementioned<br>
first-line treatment, is known as an adverse reaction<br>
that is developed most frequently. At the same time,<br>
Mycobacterium tuberculosis resistant to antitubercular<br>
agen<br><br>
The present invention provides a 2,3-dihydro-<br>
6-nitroimidazo[2,1-b]oxazole compound represented by<br>
the following general formula:<br><br>
wherein R1 represents a hydrogen atom or C1-C6 alkyl<br>
group, n represents an integer of 0 to 6, R2 represents<br>
a group -OR3 or the like, and R3 represents a hydrogen<br>
atom, C1-C6 alkyl group or the like, or R1 and -(CH2)nR2<br>
may bind to each other together with carbon atoms<br>
adjacent thereto through nitrogen atoms so as to form a<br>
spiro ring represented by the general formula (H):<br><br>
wherein R41 is hydrogen, C1-C6 alkyl group or the like.<br>
The present compound has an excellent bactericidal<br>
action against Mycobacterium tuberculosis, multi-drug-<br>
resistant Mycobacterium tuberculosis, and atypical<br>
acid-fast bacteria.<br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjAwLUtPTE5QLTIwMDUtKDIwLTEyLTIwMTEpLUNPUlJFU1BPTkRFTkNFLnBkZg==" target="_blank" style="word-wrap:break-word;">600-KOLNP-2005-(20-12-2011)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjAwLUtPTE5QLTIwMDUtKDIwLTEyLTIwMTEpLU9USEVSUy5wZGY=" target="_blank" style="word-wrap:break-word;">600-KOLNP-2005-(20-12-2011)-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjAwLUtPTE5QLTIwMDUtMS0oMjAtMTItMjAxMSktQ09SUkVTUE9OREVOQ0UtMS5wZGY=" target="_blank" style="word-wrap:break-word;">600-KOLNP-2005-1-(20-12-2011)-CORRESPONDENCE-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjAwLUtPTE5QLTIwMDUtMS0oMjAtMTItMjAxMSktT1RIRVJTLTEucGRm" target="_blank" style="word-wrap:break-word;">600-KOLNP-2005-1-(20-12-2011)-OTHERS-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjAwLUtPTE5QLTIwMDUtR1JBTlRFRCBBQlNUUkFDVC5wZGY=" target="_blank" style="word-wrap:break-word;">600-KOLNP-2005-GRANTED ABSTRACT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjAwLUtPTE5QLTIwMDUtR1JBTlRFRCBDTEFJTVMucGRm" target="_blank" style="word-wrap:break-word;">600-KOLNP-2005-GRANTED CLAIMS.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="250364-methods-for-antibody-library-screening.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="250366-process-for-industrially-producing-dialkyl-carbonate-and-diol.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>250365</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>600/KOLNP/2005</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>52/2011</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>30-Dec-2011</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>29-Dec-2011</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>08-Apr-2005</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>OTSUKA PHARMACEUTICAL CO., LTD.</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>2-9, KANDA-TSUKASACHO, CHIYODA-KU TOKYO</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>HIDETSUGU TSUBOUCHI</td>
											<td>2-35, JOTOCHO 1-CHOME, TOKUSHIMA-SHI, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>2</td>
											<td>HIDEAKI KURODA</td>
											<td>5-7, KOKUFUCHO IDO AZA MAENO, TOKUSHIMA-SHI, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>3</td>
											<td>MOTOHIRO ITOTANI</td>
											<td>89-4, MYODOCHO 3-CHOME, TOKUSHIMA-SHI, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>4</td>
											<td>TAKESHI HASEGAWA</td>
											<td>146-11-607, TOKUMEI AZA MOTOMURA, AIZUMI-CHO, ITANO-GUN, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>5</td>
											<td>YOSHIKAZU HARAGUCHI</td>
											<td>463-30-E312, KAWAUCHICHO KAGASUNO TOKUSHIMA-SHI, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>6</td>
											<td>TAKESHI KURODA</td>
											<td>24-13, EJIRI AZA EBISUNOMOTO, KITAJIMA-CHO, ITANO-GUN, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>7</td>
											<td>TAKAYUKI MATSUZAKI</td>
											<td>89, MINAMISHIMADACHO 2-CHOME, TOKUSHIMA-SHI, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>8</td>
											<td>KUNINORI TAI</td>
											<td>5-2-107, KAWAUCHICHO KANAOKA, TOKUSHIMA-SHI, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>9</td>
											<td>MAKOTO KOMATSU</td>
											<td>91-5, SASAGINO AZA HACHIYAMAKAITAKU, MATSUSHIGE-CHO, ITANO-GUN, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>10</td>
											<td>MAKOTO MATSUMOTO</td>
											<td>418, TAKASHIMA AZA KITA, NARUTOCHO, NARUTO-SHI, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>11</td>
											<td>HIROYUKI HASHIZUME</td>
											<td>527-1-1401, MINAMIHAMA AZA HIGASHIHAMA, MUYACHO, NARUTO-SHI, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>12</td>
											<td>TATSUO TOMISHIGE</td>
											<td>422-1-310, KAWAUCHICHO OKINOSHIMA, TOKUSHIMA-SHI, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>13</td>
											<td>YUJI SEIKE</td>
											<td>1-13, TATEIWA AZA KUGUHARA, MUYACHO, NARUTO-SHI, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>14</td>
											<td>MASANORI KAWASAKI</td>
											<td>9-6-306, KITATAMIYA 2-CHOME, TOKUSHIMA-SHI, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>15</td>
											<td>TAKUMI SUMIDA</td>
											<td>20-704, HIGASHISHINMACHI 2-CHOME, TOKUSHIMA-SHI, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>16</td>
											<td>SHIN MIYAMURA</td>
											<td>147-13, MUKAININOKOSHI, HIROSHIMA AZA KITAKAWA, MATSUSHIGE-CHO, ITANO-GUN, TOKUSHIMA</td>
										</tr>
										<tr>
											<td>17</td>
											<td>HIROFUMI SASAKI</td>
											<td>33-15, KITAMURA AZA SANCHOCHI, KITAJIMA-CHO, ITANO-GUN, TOKUSHIMA</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07D 498/04</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/JP2003/013070</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2003-10-10</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>2002-298259</td>
									<td>2002-10-11</td>
								    <td>Japan</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/250365-2-3-dihydro-6-nitroimidazo-2-1-b-oxazole-compound by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 14:28:44 GMT -->
</html>
